visualization during morcellation is relatively limited. This can be important for urologists early in their learning curve, as this secondary verification facilitates safer morcellation in completing this challenging operation.
INTRODUCTION AND OBJECTIVES:
The FDA approved da Vinci SP (Intuitive Surgical, Sunnyvale, CA) surgical system was developed specifically to facilitate single-site surgery, with the ideal aim to further reduce the invasiveness. We aimed to report our initial clinical experience with bladder diverticulectomy and concurrent ureteral reimplantation using the SP surgical system. Specifically, the technical points of the procedure were highlighted.
METHODS: A 54 y/o male with recurrent urinary tract infections came to our observation. Abdominal ultrasonography showed postvoided residual volume over 500 ml and left hydronephrosis. Urinary cytology was negative. Cystoscopy was performed diagnosing a bladder diverticulum, adjacent to the left ureteral orifice. Moreover, a 1.5 cm bladder stone was found. Cystogram confirmed the presence of a large diverticulum. The patient was scheduled for diverticulectomy and eventual ureteral reimplantation. After counseling, the patient accepted to undergo surgery performed using the SP surgical system. RESULTS: The robotic diverticulectomy was performed. Due to the large diverticulum and its proximity to the left distal ureter, we opted for concurrent ureteral reimplantation. The procedure was successfully performed. No intra-operative complications occurred. The operative time was 150 min. Blood losses were 50 ml. The patient was discharged on the 1st postoperative day. Bladder catheter was removed after negative cystogram on the 10th postoperative day.
CONCLUSIONS: The feasibility, the safety and the effectiveness of one-stage single-port robot-assisted bladder diverticulectomy and ureteral reimplantation using the SP Surgical System is reported herein.
Source of Funding: None.
V02-03 APPLICATION OF ROBOTIC ASSISTANCE TO TRANSPLANT URETERONEOCYSTOSTOMY
Ella Doerge*, Sapan Ambani, Ann Arbor, MI INTRODUCTION AND OBJECTIVES: Urologists are called upon to assist in management of ureteral strictures following renal transplantation. Refractory strictures can be managed with surgical reconstruction by performing ureteroneocystostomy or pyelovesicostomy. Transplant ureteroneocystostomy is often performed using an open approach. Challenges inherent to this surgery including periureteral fibrosis can be tackled with a robotic approach using advances in robotic surgical tools. Here we demonstrate our technique and rationale for performing robotic-assisted transplant ureteroneocystostomy in select patients.
METHODS: We present a single surgeon's initial case series of three patients who underwent transplant ureteroneocystostomy using the daVinciÒ robotic surgical system, as well as discuss what influences determination of a patient's candidacy for this approach.
RESULTS: Three patients with transplant ureteral strictures were identified. The median age was 61 years (26-62 years). All 3 patients failed attempts at stricture dilation. The median time from transplantation to robotic transplant ureteroneocystostomy was 7 months (6-19 months). All three patients underwent uncomplicated robotic transplant ureteroneocystostomy and were discharged on postoperative day one. All patients underwent removal of all urinary drainage tubes (foley catheter, ureteral stent, and nephrostomy tube) postoperatively in a staged fashion. At a median follow up of 11 months (3-14 months), none of the patients had evidence of hydronephrosis or renal obstruction.
CONCLUSIONS: Use of the robotic approach to transplant ureteroneocystostomy is a feasible alternative to a procedure previously done through an open Gibson incision. Performing this surgery in a minimally-invasive fashion has potential benefits of expediting postoperative recovery and minimizing wound-related complications in this immunosuppressed patient population. When applied to carefully selected patients, robotic-assisted transplant ureteroneocystostomy is a useful tool to treat transplant ureteral strictures.
Source of Funding: none

V02-04 MOSES, A NEW TECHNOLOGY FOR HOLEP
Yasser Hussein, Mohamed Ismail*, Stefano Corti, Francesca Ceresoli, Raffaella Milesi, Ivano Vavassori, Treviglio, Italy
INTRODUCTION AND OBJECTIVES:
The endoscopic technique of enucleation of the prostatic adenoma with Holmium laser (HoLEP) was introduced in 1998 by Peter Gilling. The enucleation technique and holmium laser production technology has remained almost unchanged for 20 years.
After years of research, Lumenis has developed a system capable of modify the production of the Holmium laser pulse with the Moses technology in order to optimize the laser to lithotripsy and enucleation of the prostate.
In the video we show how Moses technology can improve HoLEP execution.
METHODS: The Moses technology allows to modify the shape of the laser pulse and therefore of the plasma bubble produced by the interaction between Holmium laser and water.
The laser energy in HoLEP is used in two different ways, one is vaporization of prostate tissue making the incisions prior to the enucleation; the second mode exploits the mechanical effect called "photoacoustic effect", due to the expansion of the plasma bubble, resulting in a pressure wave that propagates to promote cleavage of tissues in course of detachment of the adenoma from the capsule during enucleation.
RESULTS: As shown the application of Moses technology during HoLEP allows a better interaction between laser and prostatic tissue; during incisions the MoSES is able to produce a vaporization of greater depth, therefore more effective, during anterograde incision; the oblong plasma bubble allows the tissue flaps to be kept out of the way, while proceeding retrograde, allowing the capsular plane already exposed to be kept under visual control, optimizing the course and duration of the incisions.
The photoacoustic effect produced with Moses technology allows obtaining a longer detachment of the tissues with respect to the conventionally produced impulse, resulting in a greater efficiency in enucleation due to the separation of longer tissue segments and for better exposure of the plan.
CONCLUSIONS: The Moses technology makes the HoLEP more effective when performed by an expert operator due to reduction of incision and enucleation times and is able to simplify the learning curve for beginners given due to the better development and exposure of enucleation plans.
